LPL Financial’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$420K Buy
172,250
+1,500
+0.9% +$3.01K ﹤0.01% 4918
2025
Q4
$234K Sell
170,750
-6,750
-4% -$8.9K ﹤0.01% 5347
2025
Q3
$220K Buy
177,500
+3,537
+2% +$4.22K ﹤0.01% 5284
2025
Q2
$197K Buy
173,963
+2,250
+1% +$2.99K ﹤0.01% 5096
2025
Q1
$251K Buy
171,713
+21,300
+14% +$40.2K ﹤0.01% 4700
2024
Q4
$320K Sell
150,413
-1,487
-1% -$3.67K ﹤0.01% 4472
2024
Q3
$425K Buy
151,900
+26,325
+21% +$70.2K ﹤0.01% 4134
2024
Q2
$293K Buy
125,575
+42,455
+51% +$125K ﹤0.01% 4283
2024
Q1
$372K Buy
83,120
+7,700
+10% +$32.1K ﹤0.01% 4031
2023
Q4
$242K Buy
75,420
+37,413
+98% +$106K ﹤0.01% 4250
2023
Q3
$120K Buy
38,007
+17,157
+82% +$75.2K ﹤0.01% 4380
2023
Q2
$104K Buy
+20,850
New +$113K ﹤0.01% 4313

Other funds holding ALLO